Skip to Main Content

Paper Details

Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
Proc Natl Acad Sci U S A
248
2021
COVID-19, SARS, SARS-CoV-, SARS-CoV-2, VeroE6 cells, coronavirus, human, human cells, neglected diseases, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Marinka ZitnikHarvard University
Marinka ZitnikHarvard University
Marinka ZitnikHarvard University
Marinka ZitnikHarvard University
Albert-L??szl?? Barab??siNetwork Science Institute, Northeastern University
Albert-L??szl?? Barab??siNortheastern University
Albert-L??szl?? Barab??siCentral European University
  • 1 - 7

Datasets

Release 1.2